These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2910189)

  • 41. Recurrent laryngeal nerve section in the treatment of spastic dysphonia.
    White JF; Knight RE
    South Med J; 1981 Sep; 74(9):1053-5. PubMed ID: 7280751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
    Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
    J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selecting the side of recurrent laryngeal nerve section for spastic dysphonia.
    Izdebski K; Dedo HH
    Otolaryngol Head Neck Surg; 1981; 89(3 Pt 1):423-6. PubMed ID: 6791104
    [No Abstract]   [Full Text] [Related]  

  • 44. Electromyographic findings in recurrent laryngeal nerve reinnervation.
    Maronian N; Waugh P; Robinson L; Hillel A
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):314-23. PubMed ID: 12731626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia.
    Guiry S; Worthley A; Simonyan K
    Laryngoscope; 2019 Jul; 129(7):1627-1633. PubMed ID: 30582159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection.
    Aronson AE; De Santo LW
    Laryngoscope; 1983 Jan; 93(1):1-8. PubMed ID: 6823165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of spastic dysphonia without nerve section.
    Friedman M; Toriumi DM; Grybauskas V; Applebaum EL
    Ann Otol Rhinol Laryngol; 1987; 96(5):590-6. PubMed ID: 3499837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An in vivo canine model for testing treatment effects in laryngeal hyperadduction disorders.
    Green DC; Berke GS
    Laryngoscope; 1990 Nov; 100(11):1229-35. PubMed ID: 2233089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
    Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow-up of recurrent laryngeal nerve avulsion for the treatment of spastic dysphonia.
    Weed DT; Jewett BS; Rainey C; Zealear DL; Stone RE; Ossoff RH; Netterville JL
    Ann Otol Rhinol Laryngol; 1996 Aug; 105(8):592-601. PubMed ID: 8712628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histology of nerves and muscles in adductor spasmodic dysphonia.
    Chhetri DK; Blumin JH; Vinters HV; Berke GS
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent laryngeal nerve pathology in spasmodic dysphonia.
    Bocchino JV; Tucker HM
    Laryngoscope; 1978 Aug; 88(8 Pt 1):1274-8. PubMed ID: 209266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent laryngeal nerve section for spastic dysphonia: 5- to 14-year preliminary results in the first 300 patients.
    Dedo HH; Behlau MS
    Ann Otol Rhinol Laryngol; 1991 Apr; 100(4 Pt 1):274-9. PubMed ID: 2018284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adductor spasmodic dysphonia: standard evaluation of symptoms and severity.
    Stewart CF; Allen EL; Tureen P; Diamond BE; Blitzer A; Brin MF
    J Voice; 1997 Mar; 11(1):95-103. PubMed ID: 9075182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spasmodic dysphonia and laryngeal botulinum toxin injection.
    Smith ME
    West J Med; 1993 Jul; 159(1):74. PubMed ID: 8351914
    [No Abstract]   [Full Text] [Related]  

  • 56. Spasmodic dysphonia: let's look at that again.
    Murry T
    J Voice; 2014 Nov; 28(6):694-9. PubMed ID: 24972536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia.
    Chhetri DK; Mendelsohn AH; Blumin JH; Berke GS
    Laryngoscope; 2006 Apr; 116(4):635-42. PubMed ID: 16585872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical therapy for vocal dysfunction.
    Snow JB
    Otolaryngol Clin North Am; 1984 Feb; 17(1):91-100. PubMed ID: 6718029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central auditory evaluation of patients with spasmodic dysphonia.
    Middleton ML; Wilson KM; Keith RW
    Ear Nose Throat J; 1997 Oct; 76(10):710-5. PubMed ID: 9345814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.